Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells

Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells

US Patent 11098053 · Granted Aug 24, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrimidines for the targeted degradation of Bruton's tyrosine kinase2024
Methods of solvent removal at ambient temperatures—cryovap2024
Inhibitors of androgen receptor signaling2023
Inhibitors of androgen receptor signaling2023
Anthranilic amides and the use thereof2022
Expression of HIV inhibitors by mesenchymal stem cells2022
Immunoprotective primary mesenchymal stem cells and methods2021
Boronic derivatives of hydroxamates as anticancer agents2021
Boronic derivatives of hydroxamates as anticancer agents2021
Surgical grafts for replacing the nipple and areola or damaged epidermis2020
Primary mesenchymal stem cells as a vaccine platform2019
Immunoprotective primary mesenchymal stem cells and methods2019